Business
Junior biotech’s shares jump 10% on good news out of the US
Image source: Getty Images
Neurizon Therapeutics Ltd (ASX: NUZ) shares are up more than 10% in early trade after the company said there had been a key development in the US for its lead investigational drug, NUZ-001.
The company stated that the US Food and Drug Administration (FDA) had lifted…
Continue Reading
-
General22 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
Noosa News24 hours agoSydney rock oysters to be grown at Lakes Entrance on the Gippsland Lakes
-
Noosa News22 hours agoWhere to Watch Live Music in Brisbane
-
Business22 hours agoWhy this ASX 200 stock could deliver a 30% return